Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease

OBJECTIVE: Widespread implementation of cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease (AD) in clinical settings requires improved accuracy for diagnosis of prodromal disease and for distinguishing AD from non‐AD dementias. Novel and promising CSF biomarkers include neurogranin, a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Clin Transl Neurol
Main Authors: Janelidze, Shorena, Hertze, Joakim, Zetterberg, Henrik, Landqvist Waldö, Maria, Santillo, Alexander, Blennow, Kaj, Hansson, Oskar
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2015
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4704480/
https://ncbi.nlm.nih.gov/pubmed/26783546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.266
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados